ALKS
Alkermes plc
ALKS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
ALKS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Weak |
ALKS's revenue is currently healthy, and its cash flow is stable, but its profitability and balance sheet are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
ALKS PE Valuation
ALKS has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
ALKS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Stable | |
| Limited | |
| Low |
ALKS has the edge over HIMS on the outlook, with more favorable earnings expectations.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
ALKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.02 | -101% |
| Q2 2026 | $0.38 | -82% |
| Q1 2026 | $0.90 | -57% |
| Q4 2025 | $1.43 | -34% |
| Q3 2025 | $2.02 | +2% |
| Q2 2025 | $2.08 | +22% |
| Q1 2025 | $2.09 | -18% |
| Q4 2024 | $2.17 | +3.3% |
ALKS has swung to a loss: it lost $0.02 per share over the past year, after a profit the year before.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over ALKS on earnings, with more consistent year-over-year improvement.
ALKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $480.1M | +22% |
| Q2 2026 | $496M | +27% |
| Q1 2026 | $392.9M | +28% |
| Q4 2025 | $384.5M | -11% |
| Q3 2025 | $394.2M | +4.2% |
| Q2 2025 | $390.7M | -2.1% |
| Q1 2025 | $306.5M | -13% |
| Q4 2024 | $430M | +14% |
ALKS's revenue is recovering but still below its 2023 peak: $480M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.5% | -15 points |
| Q2 2026 | 3.7% | -20 points |
| Q1 2026 | -12% | -17 points |
| Q4 2025 | 15% | -23 points |
| Q3 2025 | 23% | -5.1 points |
| Q2 2025 | 24% | -3.7 points |
| Q1 2025 | 4.5% | -7.9 points |
| Q4 2024 | 38% | -9.5 points |
ALKS has the edge over HIMS on profitability, with a higher operating margin.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over ALKS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
ALKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $90.1M | +6.8% |
| Q2 2026 | $137M | -0.1% |
| Q1 2026 | -$169.8M | -291% |
| Q4 2025 | $170.1M | -5.8% |
| Q3 2025 | $84.4M | +15% |
| Q2 2025 | $137.2M | -1.2% |
| Q1 2025 | $88.7M | +595% |
| Q4 2024 | $180.6M | +100% |
ALKS still generates free cash flow, though less than at its 2023 peak: $227M over the past year.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over ALKS on cash flow, with more consistent year-over-year improvement.
ALKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +2.9M shares |
| 1 year | +4.7% | +7.9M shares |
| 3 years | +2.6% | +4.5M shares |
| 5 years | +9.2% | +14.9M shares |
| Available history | +12% | +19.3M shares |
ALKS has 176M diluted shares, up 4.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $27.7M |
| Q4 2024 | $1,000 |
| Q3 2024 | $115.6M |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over ALKS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
ALKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.0x | High |
| Q2 2026 | 5.5x | High |
| Q1 2026 | 5.0x | High |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q3 2024 | -0.2x | Net Cash |
ALKS's net debt is about 6.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
ALKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.9 | Neutral |
| Stochastic | 53.5 | Neutral |
ALKS's weekly RSI is 59 (neutral) and its Stochastic is 53 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
ALKS PE vs Healthcare Sector
| Metric | ALKS | Sector median | Relative |
|---|---|---|---|
| PE | 119x | 26x | 362% above |
| PE % | 96 | 29 | 67 pts above |
ALKS has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
ALKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $43.3 | 8.5% above |
| 20 week MA | $46.8 | 0.3% above |
| 50 week MA | $39.2 | 20% above |
| 100 week MA | $34.7 | 35% above |
| 200 week MA | $31.2 | 51% above |
ALKS has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
ALKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.4 | $21.5 | +5% |
| 2021 | $21.5 | $24.1 | +12% |
| 2022 | $24.1 | $25.5 | +5.8% |
| 2023 | $25.5 | $27.7 | +8.8% |
| 2024 | $27.7 | $29.6 | +6.5% |
| 2025 | $29.6 | $28.5 | -3.6% |
| 2026 YTD | $28.5 | $47.0 | +65% |
ALKS has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.